Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK2 | O75116 | 1/20 | 0.35 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 3/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | HCRTR2 | O43614 | 3/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13355186 | 0.94 | LMNA (0.36) | LMNACHRM2CHRM4CHRM1CHRM3 | |
| SCHEMBL18354412 | 0.86 | TP53 (0.34) | LMNACHRM2CHRM4CHRM1CHRM3 | |
| SCHEMBL18354358 | 0.86 | TP53 (0.34) | LMNACHRM2CHRM4CHRM1CHRM3 | |
| SCHEMBL18354410 | 0.86 | TP53 (0.34) | LMNACHRM2CHRM4CHRM1CHRM3 | |
| SCHEMBL3784779 | 0.84 | SHBG (0.40) | LMNACHRM2CHRM4CHRM1CHRM3 | |
| SCHEMBL27675100 | 0.82 | CHRNB2 (0.32) | LMNAALOX5 | |
| SCHEMBL27675099 | 0.82 | CHRNB2 (0.32) | LMNAALOX5 | |
| SCHEMBL28771692 | 0.81 | CPN1 (0.41) | LMNACHRM2CHRM4CHRM1CHRM3 | |
| SCHEMBL25293694 | 0.79 | LMNA (0.32) | LMNACHRM2CHRM4CHRM1CHRM3 | |
| SCHEMBL28377083 | 0.78 | LMNA (0.32) | LMNAMEN1CYP2C19RECQLKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 177 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10682533-B2 | Multi-capsule compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2020-06-16 | — | — | US | claimed |
| US-9770608-B2 | Multi-capsule compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2017-09-26 | — | — | US | claimed |
| US-20170145347-A1 | MULTI-CAPSULE COMPOSITIONS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2017-05-25 | — | — | US | claimed |
| WO-2016106362-A1 | LIQUID FABRIC CONDITIONING COMPOSITIONS | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2016-06-30 | — | — | WO | claimed |
| US-20150132377-A1 | MULTI-CAPSULE COMPOSITIONS | INTERNATIONAL FLAVORS AND FRAGRANCES INC. | 2015-05-14 | — | — | US | claimed |
| US-8012554-B2 | Bags having odor management capabilities | PACTIV CORPORATION (US) | 2011-09-06 | — | — | US | claimed |
| EP-1532990-B1 | Deodorizing compositions containing zinc ricinoleate and at least one substituted monocyclic organic compound | INT FLAVORS & FRAGRANCES INC (US) | 2010-02-17 | — | — | EP | claimed |
| WO-2009035740-A1 | BAGS HAVING ODOR MANAGEMENT CAPABILITIES | PACTIV CORPORATION (US) | 2009-03-19 | — | — | WO | claimed |
| US-20090067760-A1 | BAGS HAVING ODOR MANAGEMENT CAPABILITIES | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT AND COLLATERAL AGENT | 2009-03-12 | — | — | US | claimed |
| EP-1447102-B1 | Cyclohexylethan-1-yl ester mixtures as malodour counteractants and methods for using same | INT FLAVORS & FRAGRANCES INC (US) | 2008-06-04 | — | — | EP | claimed |
| EP-1533415-B1 | Melamine-formaldehyde microcapsule slurries for fabric article freshening | INT FLAVORS & FRAGRANCES INC (US) | 2007-02-14 | — | — | EP | claimed |
| US-20050113282-A1 | Melamine-formaldehyde microcapsule slurries for fabric article freshening | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2005-05-26 | — | — | US | claimed |
| EP-1533415-A1 | Melamine-formaldehyde microcapsule slurries for fabric article freshening | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2005-05-25 | — | — | EP | claimed |
| EP-1532990-A1 | Deodorizing compositions containing zinc ricinoleate and at least one substituted monocyclic organic compound | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2005-05-25 | — | — | EP | claimed |
| US-20050106192-A1 | Synergistically-effective composition of zinc ricinoleate and one or more substituted monocyclic organic compounds and use thereof for preventing and/or suppressing malodors | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2005-05-19 | — | — | US | claimed |
| EP-1447102-A1 | Cyclohexylethan-1-yl ester mixtures as malodour counteractants and methods for using same | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2004-08-18 | — | — | EP | claimed |
| US-20040156742-A1 | Synergistically-effective cyclohexylethan-1-yl ester mixtures as malodour counteractants as measured physiologically and psychometrically and methods for using same | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2004-08-12 | — | — | US | claimed |
| US-11987771-B2 | Fabric spray composition comprising a non-functionalized silicone nanoemulsion and peg-40 hydrogenated castor oil | CONOPCO, INC. (US) | 2024-05-21 | — | — | US | disclosed |
| EP-1447102-A1 | Cyclohexylethan-1-yl ester mixtures as malodour counteractants and methods for using same | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2004-08-18 | — | — | EP | disclosed |
| US-20040156742-A1 | Synergistically-effective cyclohexylethan-1-yl ester mixtures as malodour counteractants as measured physiologically and psychometrically and methods for using same | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2004-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10682533-B2 | Multi-capsule compositions | CAPG, GNE, RIMKLA | ROCK2 3342/4885ROCK1 4172/4885LMNA 1248/4885 |
| US-20050106192-A1 | Synergistically-effective composition of zinc ricinoleate and one or more substituted monocyclic organic compounds and use thereof for preventing and/or suppressing malodors | MAL2, ME1, MALT1 | ROCK2 3449/4885ROCK1 3438/4885LMNA 2841/4885 |
| US-20150132377-A1 | MULTI-CAPSULE COMPOSITIONS | CAPG, GNE, RIMKLA | ROCK2 3342/4885ROCK1 4172/4885LMNA 1248/4885 |
| US-20050113282-A1 | Melamine-formaldehyde microcapsule slurries for fabric article freshening | CHRM5, AUP1, SMS | ROCK2 4358/4885ROCK1 4082/4885LMNA 809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.